Short-term antibody response and tolerability after one dose of BNT162b2 vaccine in patients receiving hemodialysis: A report from the Quebec Renal Network COVID-19 study

Rémi Goupil, Mehdi Benlarbi, William Beaubien-Souligny, Annie-Claire Nadeau-Fredette, Debashree Chatterjee, Guillaume Goyette, Caroline Lamarche, Alexander Tom, Andrés Finzi, Rita S. Suri on behalf of the Réseau Rénal Québécois (Quebec Renal Network) COVID-19 Study Investigators
doi: https://doi.org/10.1101/2021.03.30.21254652

Article usage

Article usage: April 2021 to June 2025

AbstractFullPdf
Apr 2021103936270
May 202171561102
Jun 20219306193
Jul 20217641566
Aug 20211011819
Sep 2021801328
Oct 2021781013
Nov 202163925
Dec 202148510
Jan 202246513
Feb 20223535
Mar 20223346
Apr 202233017
May 202229716
Jun 2022421161
Jul 2022237135
Aug 202234410
Sep 202235111
Oct 202234156
Nov 20222003
Dec 202220412
Jan 20233838
Feb 20234778
Mar 20231622
Apr 20233179
May 202319510
Jun 2023855
Jul 2023946
Aug 2023222110
Sep 20231677
Oct 202320117
Nov 2023342011
Dec 202318116
Jan 20241473
Feb 2024211313
Mar 2024241010
Apr 2024131611
May 20241879
Jun 20241465
Jul 2024171013
Aug 2024362014
Sep 2024281611
Oct 20249112
Nov 202415811
Dec 20241579
Jan 20251994
Feb 202515335
Mar 2025393414
Apr 20251956
May 2025312011
Jun 2025532
Back to top
Posted April 08, 2021.
Download PDF
Data/Code
Email
Short-term antibody response and tolerability after one dose of BNT162b2 vaccine in patients receiving hemodialysis: A report from the Quebec Renal Network COVID-19 study
Rémi Goupil, Mehdi Benlarbi, William Beaubien-Souligny, Annie-Claire Nadeau-Fredette, Debashree Chatterjee, Guillaume Goyette, Caroline Lamarche, Alexander Tom, Andrés Finzi, Rita S. Suri
medRxiv 2021.03.30.21254652; doi: https://doi.org/10.1101/2021.03.30.21254652
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area